FDA issues untitled letters to Sanofi and Viatris for false advertising
<p>The FDA’s Office of Prescription Drug Promotion recently reprimanded Sanofi and Viatris for making misleading claims about their products in emails and a television advertisement.</p>
21 Jul 2026 European Commission publishes guideline on transparency obligations under AI Act The European Commission on Monday published new guidelines to assist providers and deployers of artificial intelligence (AI) systems in fulfilling transparency obligations under the EU’s AI Act, including examples of exceptions to these requirements. While not specific to healthcare products, companies developing healthcare products with an AI system component may be subject to transparency rules. Regulatory News
comments(0)
5-min edit window · permanent after that